GLOBUS MEDICAL, INC. (GMED) Operating cash flow 2016–2025
GLOBUS MEDICAL, INC. (GMED) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$753.4MFY2025 · since FY2016: $147.8M → $753.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $753.4M | +44.7% |
| FY2024 | $520.6M | +113.8% |
| FY2023 | $243.5M | +36.4% |
| FY2022 | $178.5M | -35.4% |
| FY2021 | $276.3M | +39.0% |
| FY2020 | $198.8M | +15.6% |
| FY2019 | $172.0M | -5.3% |
| FY2018 | $181.6M | +14.2% |
| FY2017 | $159.1M | +7.6% |
| FY2016 | $147.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GMED financial trends
GMED RevenueGMED Net incomeGMED Net marginGMED Gross profitGMED Gross marginGMED Operating incomeGMED Operating marginGMED Free cash flowGMED Capital expendituresGMED Return on equityGMED Stock buybacksGMED Dividends paidGMED Total assetsGMED Total liabilitiesGMED Shareholders’ equityGMED overview →